At the 18th European Conference on Computational Biology and the 27th Conference on Intelligent Systems for Molecular Biology, IBM will present significant, novel research that led to the implementation of three machine learning solutions aimed at accelerating and guiding cancer research.
A comprehensive analysis of tumor ecosystems that represents an important step in research that may lead to precision medicine approaches to treat breast cancer.
New research shows that the number of mitochondria in a cell is associated with drug resistance, which could have a far-reaching impact in cancer treatment.
Biophysics-inspired AI tools would provide a richer amount of information to support intraoperative decisions of surgeons during removal of cancerous tissue.
Cancer continues to be a deadly threat to more than 14 million people who are diagnosed each year around the world. At the same time, five-year survival rates have been steadily improving over the last three decades to nearly 70 percent, according to the American Cancer Society. However, current cancer treatment regimens, such as traditional […]
Published in Science: IBM and Memorial Sloan Kettering researchers solve cancer immunotherapy mystery
Cancer immunotherapies, treatment approaches which harness a person’s own immune system to target and kill cancer cells, are currently a major driver in the development of new cancer treatments. With the advent of next-generation gene editing technologies like CRISPR-Cas9, one could imagine a future in which cancer treatments are tailor-made not only for particular cancer […]
Just last month, IBM released its “5 in 5” predictions, an exercise to identify five innovations that will have an impact on society in five years. Among the five, it was predicted that, with the help of IBM “lab-on-a-chip” technology, doctors could have a device that isolates tiny bioparticles from bodily fluids to reveal signs […]
Since the time of Egyptians building pyramids, we’ve known about the impact cancer has on humankind. It is the second leading cause of death in the US1, based on data from 2010 through 2012, nearly 40 percent of Americans will develop it in their lifetime; one in four men and one in five women are […]